COMPLIANCE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS: 5-YEARS FOLLOW-UP OF THE RUSSIAN FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY

被引：0
|
作者：
Chubykina, U. [1 ]
Ezhov, M. [1 ]
Shaposhnik, I. [2 ]
Genkel, V. [2 ]
Ershova, A. [3 ]
Gurevich, V. [4 ]
Filippov, A. [5 ]
Voevoda, M. [6 ]
机构：
[1] Minist Hlth, FSBI Natl Med Res Ctr Cardiol EI Chazov, Lab Lipid Disorders, Moscow, Russia
[2] South Ural State Med Univ, Cardiol, Chelyabinsk, Russia
[3] Natl Med Res Ctr Therapy & Prevent Med, Lab Clinom, Moscow, Russia
[4] St Petersburg State Univ, Ctr Atherosclerosis & Lipid Disorders, St Petersburg, Russia
[5] St Petersburg State Univ, Cardiol, St Petersburg, Russia
[6] IIPM, Cardiol, Novosibirsk, Russia
来源：
ATHEROSCLEROSIS | 2023年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P264
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia:: A prospective clinical follow-up study
    Hedman, M
    Matikainen, T
    Föhr, A
    Lappi, M
    Piippo, S
    Nuutinen, M
    Antikainen, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04): : 1942 - 1952
  • [22] Long-term follow-up of carotid atherosclerosis in patients with heterozygous familial hypercholesterolemia under LDL apheresis treatment
    Donner, MG
    Richter, WO
    Schwandt, P
    JOURNAL OF CLINICAL APHERESIS, 1997, 12 (04) : 202 - 203
  • [23] ANALYSIS OF UKRAINIAN REGISTRY OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Chulaievska, N.
    Mitchenko, O.
    Romanov, V.
    Yakuschko, L.
    ATHEROSCLEROSIS, 2019, 287 : E207 - E208
  • [24] 5 YEARS FOLLOW-UP OF A MALE-PATIENT HOMOZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH REPEATED PLASMA EXCHANGES
    WIDHALM, K
    PEDIATRIC RESEARCH, 1987, 22 (02) : 236 - 236
  • [25] GENETIC ANALYSIS IN RUSSIAN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Shakhtshneider, E.
    Ivanoshchuk, D.
    Timoshchenko, O.
    Orlov, P.
    ATHEROSCLEROSIS, 2021, 331 : E180 - E180
  • [26] POLYGENETIC ABNORMALITIES IN JAPANESE PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Sekiguchi, Haruki
    Koike, Toshiharu
    Abe, Takuro
    Sakai, Akiko
    Sato, Kayoko
    Hagiwara, Nobuhisa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1756 - 1756
  • [27] CORONARY ANGIOGRAPHIC CHARACTERISTICS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    GENDA, A
    UMEDA, K
    NAKAYAMA, A
    SHIMIZU, M
    KONISHI, K
    SUGIHARA, N
    SUEMATZU, T
    KITA, Y
    YOSHIMURA, A
    MABUCHI, H
    TAKEDA, R
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1987, 51 (08): : 940 - 940
  • [28] Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemia
    Elisaf, M
    Bairaktari, H
    Siamopoulos, KC
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 53 (03) : 314 - 316
  • [29] When should patients with heterozygous familial hypercholesterolemia be treated?
    Rifkind, BM
    Schucker, B
    Gordon, DJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02): : 180 - 181
  • [30] Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
    Nicholls, Stephen
    Nelson, Adam
    Ditmarsch, Marc
    Kastelein, John
    Ballantyne, Christie
    Ray, Kausik
    Navar, Ann Marie
    Nissen, Steven
    Goldberg, Anne
    Brunham, Liam
    Wuerdeman, Erin
    Neild, Annie
    Kling, Douglas
    Hsieh, Andrew
    Ference, Brian
    Laufs, Ulrich
    Banach, Maciej
    Mehran, Roxana
    Catapano, Alberico
    Davidson, Michael
    CIRCULATION, 2024, 150 (25) : E729 - E730
12345